Wes Streeting: Children Cannot Self-Enroll in Puberty Blocker Trials

A £10 million trial assessing the benefits and risks of puberty blockers for trans youth will proceed despite opposition from the Conservative Party. Health Secretary Wes Streeting, who previously banned the drug due to safety concerns, emphasized that the trial follows recommendations from the Cass Review and has ethical approval. The study will involve 226 participants under 16, with results expected in four years. Streeting reaffirmed the importance of prioritizing children’s safety in the trial’s implementation.

Want More Context? 🔎